E3 PreliminaryPreliminaryPEM ?ObservationalPeer-reviewedMachine draft
Dehydroepiandrosterone (DHEA) response to i.v. ACTH in patients with chronic fatigue syndrome.
De Becker, P, De Meirleir, K, Joos, E et al. · Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · 1999 · DOI
Quick Summary
This study tested how the adrenal glands respond to a hormone signal in ME/CFS patients compared to healthy people. Researchers gave a hormone called ACTH to 22 ME/CFS patients and 14 healthy controls, then measured DHEA levels over an hour. While starting DHEA levels were normal, ME/CFS patients showed a weaker increase in DHEA after the hormone injection compared to healthy controls.
Why It Matters
This research provides direct evidence of abnormal adrenal gland function in ME/CFS, supporting the theory that hormonal dysregulation—specifically inadequate stress hormone responses—may underlie some of the immune system disturbances and fatigue symptoms patients experience. Understanding these endocrine abnormalities could eventually lead to targeted hormone-based treatments for ME/CFS.
Observed Findings
- Normal basal serum DHEA levels in both CFS patients and healthy controls
- Blunted serum DHEA response curve to intravenous ACTH injection in CFS patients compared to controls
- Differential adrenal gland response to ACTH stimulation between patient and control groups despite similar baseline hormone levels
Inferred Conclusions
- ME/CFS involves endocrinological abnormalities including adrenal insufficiency in DHEA production
- Relative glucocorticoid deficiency may contribute to the clinical presentation of ME/CFS
- Adrenal dysfunction could partially explain immunological disturbances observed in ME/CFS patients
Remaining Questions
- Does correcting the blunted DHEA response through supplementation improve ME/CFS symptoms or immune function?
- Is this adrenal dysfunction present in all ME/CFS patients or only a subgroup, and does it correlate with symptom severity?
- What causes the adrenal glands to mount an inadequate DHEA response to ACTH in ME/CFS?
- Do DHEA response patterns change over time or correlate with disease progression?
What This Study Does Not Prove
This study does not prove that the blunted DHEA response causes ME/CFS symptoms or is the primary driver of disease. It also does not establish whether this adrenal dysfunction is a cause, consequence, or marker of the disease process, nor does it demonstrate whether correcting this response would improve patient outcomes.
Tags
Symptom:Fatigue
Biomarker:Blood Biomarker
Method Flag:PEM Not DefinedSmall SampleExploratory Only
Metadata
- DOI
- 10.1055/s-2007-978690
- PMID
- 10077344
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 8 April 2026